Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Monday, December 23, 2024 · 771,268,129 Articles · 3+ Million Readers

Blood Plasma Injections for Hair Loss and Balding: Lilac Corp Recommends Nolopecia

All natural hair loss supplement sold by Lilac Corp

Lilac Corp summarizes a paper on platelet rich plasma (PRP) treatment for hair loss, and recommends Nolopecia, a natural treatment for stimulating hair growth.

There are many treatments for hair loss on the market. However only Nolopecia targets the latent viruses that cause the increase in 5alpha-R, DHT, and AR observed in people with hair loss and balding.”
— Lilac Corp
SARASOTA, FL, UNITED STATES, June 19, 2018 /EINPresswire.com/ -- A new scientific article [1] discusses the platelet-rich plasma (PRP) treatment for hair loss. PRP is prepared by taking a patient’s own blood and extracting its hair growth factors. Then, the extract is injected into the patient's scalp. This treatment has been shown to promote hair growth in several studies, especially when combined with other treatments. The article mentions two recent studies that showed that PRP increased hair growth in 60 patients over a period of 12 months. Furthermore, in 13 other studies PRP was shown to be a promising biologic treatment for hair loss. Studies also showed that hair regrowth is increased when PRP is added to a 6-month treatment of finasteride or minoxidil.

For men and women who suffer from hair loss and balding, Lilac Corp recommends the natural treatment Nolopecia. The new treatment targets the latent viruses in the body. This helps the body maintain a normal level of the 5alpha-R, DHT, and AR proteins. A normal level of these proteins stimulates hair growth. There are many treatments for hair loss on the market. However, only Nolopecia targets the latent viruses that cause the increase in 5alpha-R, DHT, and AR observed in people with hair loss and balding.

Lilac Corp is the company that invented the highly effective and unique antiviral natural treatments Gene-Eden-VIR and Novirin. For more information on these products, see lilaccorp.com, or search Google. The search will produce the clinical studies that tested the treatments and showed the safety and effectiveness of the treatments. See also references below.

About Lilac Corp:
Lilac Corp specializes in the development of biology-based patent protected natural treatments. Currently, Lilac Corp is selling four products: Gene-Eden-VIR, Novirin, Nolopecia, and Noacnin. Lilac Corp ships its products to more than 100 countries around the world. What makes Lilac Corp special is that all its products are tested in clinical studies that follow FDA guidelines. To ensure transparency, the results of the clinical studies are published in leading scientific journals. Lilac Corp also offers a 90-day money back guarantee.

Sources:
[1] Anitua E, Pino A, Jaén P, Navarro R. Platelet rich plasma for the management of hair loss: Better alone or in combination?. J Cosmet Dermatol. 2018;00:1–4.

[2] Polansky H, Javaherian A, Itzkovitz E. Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus acyclovir, valacyclovir, and famciclovir. Drug Des Devel Ther. 2016 Aug 29;10:2713-22

[3] Polansky H, Itzkovitz E, Javaherian A. Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases. Clin Transl Med. 2016 Dec;5(1):40.

[4] Polansky H, Itzkovitz E, Javaherian A. Human papillomavirus (HPV): systemic treatment with Gene-Eden-VIR/Novirin safely and effectively clears virus. Drug Des Devel Ther. 2017 Mar 3; 11:575-583

John Evans
Lilac Corp
585-250-9999
email us here

Powered by EIN Presswire

Distribution channels: Beauty & Hair Care, Consumer Goods, Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry, Science

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release